NCT02101229View on ClinicalTrials.gov

Validation of the Artificial Pancreas Diabeloop Algorithm in the Hospital

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
Type 1 Diabetes
Interventions
DRUG

Insulin, Asp(B28)-

"the insulin dose is calculated by the Diabeloop algorithm and then administered to the patient"

Trial Locations (3)

34295

University Hospital of Montpellier, Montpellier

38043

University Hospital of Grenoble, Grenoble

91058

Centre Hospitalier du Sud Francillien, Évry

All Listed Sponsors
lead

Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète

OTHER

NCT02101229 - Validation of the Artificial Pancreas Diabeloop Algorithm in the Hospital | Biotech Hunter | Biotech Hunter